21 CFR Subpart G
Tumor Associated Antigen immunological Test Systems
June 25, 2020
§
866.6010
Tumor-associated antigen immunological test system
§
866.6020
Immunomagnetic circulating cancer cell selection and enumeration system
§
866.6030
AFP-L3% immunological test system
§
866.6040
Gene expression profiling test system for breast cancer prognosis
§
866.6050
Ovarian adnexal mass assessment score test system
§
866.6060
BCR-ABL quantitation test
§
866.6080
Next generation sequencing based tumor profiling test
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
